Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), MRCGP (Medicine), FRCGP
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Infectious Disease Specialist
MBBS, FCPS (Medicine), FCPS (Infectious Diseases)
Infectious Disease Specialist
MBBS, FCPS (Medicine), FCPS (Infectious Diseases)
Cardiologist
MBBS, FCPS
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Endocrinologist
MBBS (Gold Medalist), FCPS (Internal Medicine), F.C.P.S. (Endocrinology), Fellowship in Diabetes, Endocrine and Metabolism(AKUH), SCE Endocrine & Diabetes (UK)
Diabetologist
F.C.P.S., M.B.B.S.
Hepatologist
Fellow Of American College Of Gastroenterology, MBBS, MRCP (UK), FRCP (Edin)
Hepatologist
Fellow Of American College Of Gastroenterology, MBBS, MRCP (UK), FRCP (Edin)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures